Susan M Chang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Susan M Chang

Showing results (281-290 of 386) with videos related to

Pageof 39

Sort By:

International Journal of Radiation Oncology, Biology, Physics|October 12, 2010

A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021

Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.

Neuro-Oncology|February 13, 2010

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomasJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.

Neuro-Oncology|October 28, 2017

Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomasJosie Hayes, Yao Yu, Llewellyn E Jalbert, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.

Neuro-Oncology|February 13, 2010

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.

Neuro-Oncology|January 9, 2022

Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsRiccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011

It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.

Magnetic Resonance in Medicine|June 6, 2020

Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized <sup>13</sup> C MRSIHsin-Yu Chen, Adam W Autry, Jeffrey R Brender, et al.

Pageof 39

Search research articles

Showing results (281-290 of 386) with videos related to

Sort By:

Pageof 39

International Journal of Radiation Oncology, Biology, Physics|October 12, 2010

A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021

Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.

Neuro-Oncology|February 13, 2010

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.

Neuro-Oncology|October 28, 2017

Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomasJosie Hayes, Yao Yu, Llewellyn E Jalbert, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.

Neuro-Oncology|February 13, 2010

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.

Neuro-Oncology|January 9, 2022

Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsRiccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011

It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.

Magnetic Resonance in Medicine|June 6, 2020

Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized <sup>13</sup> C MRSIHsin-Yu Chen, Adam W Autry, Jeffrey R Brender, et al.

Pageof 39